| Primary |
| Dry Eye |
12.6% |
| Eye Allergy |
9.2% |
| Off Label Use |
9.2% |
| Conjunctivitis Allergic |
8.0% |
| Eye Inflammation |
6.9% |
| Keratoconjunctivitis Sicca |
6.9% |
| Eye Pruritus |
5.7% |
| Hypersensitivity |
5.7% |
| Lacrimation Increased |
5.7% |
| Ocular Hyperaemia |
5.7% |
| Erythema Of Eyelid |
3.4% |
| Seasonal Allergy |
3.4% |
| Blepharitis |
2.3% |
| Episcleritis |
2.3% |
| Eye Swelling |
2.3% |
| Eyelid Oedema |
2.3% |
| Giant Papillary Conjunctivitis |
2.3% |
| Hypertension |
2.3% |
| Postoperative Care |
2.3% |
| Arthropod Bite |
1.1% |
|
| Drug Ineffective |
16.2% |
| Drug Hypersensitivity |
13.5% |
| Vision Blurred |
8.1% |
| Eye Irritation |
5.4% |
| Intraocular Pressure Increased |
5.4% |
| Ocular Hyperaemia |
5.4% |
| Pruritus Generalised |
5.4% |
| Swelling Face |
5.4% |
| Urticaria |
5.4% |
| Corneal Opacity |
2.7% |
| Dermatitis Contact |
2.7% |
| Dizziness |
2.7% |
| Drug Exposure During Pregnancy |
2.7% |
| Drug Ineffective For Unapproved Indication |
2.7% |
| Epistaxis |
2.7% |
| Erythema Of Eyelid |
2.7% |
| Eye Pruritus |
2.7% |
| Eye Swelling |
2.7% |
| Halo Vision |
2.7% |
| Insomnia |
2.7% |
|
| Secondary |
| Dry Eye |
14.2% |
| Off Label Use |
11.1% |
| Eye Pruritus |
9.5% |
| Keratoconjunctivitis Sicca |
8.9% |
| Hypersensitivity |
7.9% |
| Eye Allergy |
6.3% |
| Ocular Hyperaemia |
6.3% |
| Episcleritis |
4.2% |
| Eye Inflammation |
3.7% |
| Eye Swelling |
3.7% |
| Seasonal Allergy |
3.7% |
| Erythema Of Eyelid |
3.2% |
| Eye Irritation |
3.2% |
| Eyelid Oedema |
3.2% |
| Intraocular Pressure Increased |
2.6% |
| Mineral Supplementation |
2.6% |
| Vitamin Supplementation |
2.6% |
| Lacrimation Increased |
1.6% |
| Vision Blurred |
1.1% |
| Contraception |
0.5% |
|
| Dermatitis Contact |
13.7% |
| Reaction To Preservatives |
13.7% |
| Erythema Of Eyelid |
11.8% |
| Intraocular Pressure Increased |
9.8% |
| Lacrimation Increased |
9.8% |
| Thirst |
5.9% |
| Vision Blurred |
5.9% |
| Drug Ineffective |
3.9% |
| Halo Vision |
3.9% |
| Corneal Opacity |
2.0% |
| Drug Hypersensitivity |
2.0% |
| Drug Ineffective For Unapproved Indication |
2.0% |
| Epistaxis |
2.0% |
| Eye Operation |
2.0% |
| Eye Pruritus |
2.0% |
| Eye Swelling |
2.0% |
| Ocular Hyperaemia |
2.0% |
| Sneezing |
2.0% |
| Ulcerative Keratitis |
2.0% |
| Visual Field Defect |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
18.6% |
| Drug Use For Unknown Indication |
15.6% |
| Dry Eye |
11.4% |
| Rosacea |
7.2% |
| Bipolar Disorder |
4.2% |
| Blood Cholesterol Increased |
4.2% |
| Hypertension |
4.2% |
| Osteoporosis |
4.2% |
| Chronic Obstructive Pulmonary Disease |
3.6% |
| Hypersensitivity |
3.6% |
| Arthralgia |
3.0% |
| Anaesthesia |
2.4% |
| Blepharospasm |
2.4% |
| Crohn's Disease |
2.4% |
| Fibromyalgia |
2.4% |
| Nerve Block |
2.4% |
| Pain |
2.4% |
| Skin Wrinkling |
2.4% |
| Atrial Fibrillation |
1.8% |
| Irritable Bowel Syndrome |
1.8% |
|
| Vision Blurred |
15.4% |
| Hip Fracture |
7.7% |
| Panic Attack |
7.7% |
| Unevaluable Event |
7.7% |
| Abnormal Sensation In Eye |
3.8% |
| Asthenia |
3.8% |
| Bipolar Disorder |
3.8% |
| Bladder Cancer |
3.8% |
| Chronic Obstructive Pulmonary Disease |
3.8% |
| Death |
3.8% |
| Diarrhoea |
3.8% |
| Dizziness |
3.8% |
| Drug Ineffective |
3.8% |
| Ear Discomfort |
3.8% |
| Eye Irritation |
3.8% |
| Febrile Neutropenia |
3.8% |
| Hypersensitivity |
3.8% |
| Injection Site Haemorrhage |
3.8% |
| Injection Site Pain |
3.8% |
| Joint Effusion |
3.8% |
|
